Summary
Aaron Cooper is a life-sciences leader with a decade of experience building early discovery capabilities at the intersection of synthetic biology, gene editing, large-scale viral vector manufacturing, and computational genomics. As Vice President of Early Discovery at ArsenalBio, he leads cross-functional efforts to translate high-throughput screening, cell barcoding, and AI-driven analysis into therapeutic candidates and platform technologies. His background spans hands-on vector production and molecular assay design to bioinformatics for integration-site and CRISPR studies, enabling him to bridge wet lab innovation with scalable discovery pipelines. Previously he led platform development at Octant and advanced viral and synthetic receptor programs across industry and academia, reflecting a consistent focus on automating and scaling complex biological assays. Based in South San Francisco with a PhD from UCLA, he combines deep technical expertise with product-oriented leadership that accelerates translation from discovery to clinic.
10 years of coding experience
3 years of employment as a software developer
Bachelor of Arts (B.A.), Biology, Bachelor of Arts (B.A.), Biology at Pomona College
Doctor of Philosophy (Ph.D.), Molecular Biology, Doctor of Philosophy (Ph.D.), Molecular Biology at University of California, Los Angeles